FindTrial
Sign In

Study on impact of yoga on symptoms, biomarkers, heart rate variability and cognition among female students with premenstrual syndrome

Efficacy of Integrated Yoga on the symptoms of premenstrual syndrome, biomarkers, heart rate variability, quality of life and cognitive functions among female university students with premenstrual syndrome: a randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085497
Enrollment
48
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

Intervention1: Yoga therapy: A 60-minute validated yoga module comprising sukshma vyamas(loosening practies), asana (postures),pranayamas (voluntary regulated breathing), mudras (hand-gestures), relax

Sponsors

Dr Kashinath G Metri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Consenting female university students with PMS residing in the university hostels 2) Females within the age range 18-30 years 3) Must stay in university campus hostels

Exclusion criteria

Exclusion criteria: 1) Females diagnosed with other gynecological disorders, physical or mental disorders, and menstrual irregularities 2) Females undergoing any long term medications 3) Females who are overweight or obese 4) Females with history of addiction or substance abuse 5) Females who has been exposed to yoga practices in the past 6 months 6) Females recieving any other mind-body therapies

Design outcomes

Primary

MeasureTime frame
1) Biomarkers: Progesterone and Serotonin 2) Cognitive functions: sustained attention, working memory, and executive function (inhibitory control) 3) Symptoms of Premenstrual syndrome, Profiles of mood states, Premenstrual syndrome related quality of lifeTimepoint: Baseline (0 week), post (after 8 weeks), and follow-up (after 12 weeks)—

Secondary

MeasureTime frame
1) Cardiac autonomic function: Heart rate variability 2) Sleep quality 3) Menstrual pain.Timepoint: Baseline (0 week), post (after 8 weeks), and follow-up (after 12 weeks)—

Countries

India

Contacts

Public ContactDr Kashinath G Metri

Central University of Rajasthan

2023phdyg002@curaj.ac.in6001785253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026